785688002: Carbidopa anhydrous (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)\Carbidopa anhydrous
\Substance categorized by disposition\Receptor agonist\Dopamine receptor agonist\Dihydroxyphenylalanine\Carbidopa anhydrous

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa anhydrous

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Catecholamine and/or catecholamine derivative\Catecholamine\Dihydroxyphenylalanine\Carbidopa anhydrous

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3767988015 Carbidopa anhydrous en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3767989011 Carbidopa anhydrous (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4351501000052115 karbidopa, vattenfritt sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbidopa anhydrous	Has disposition (attribute)	Dihydroxyphenylalanine decarboxylase inhibitor (disposition)	true	Inferred relationship	Some
Carbidopa anhydrous	Is a	Dihydroxyphenylalanine	true	Inferred relationship	Some
Carbidopa anhydrous	Is modification of (attribute)	Carbidopa	true	Inferred relationship	Some
Carbidopa anhydrous	Has disposition (attribute)	Dopamine receptor agonist (disposition)	true	Inferred relationship	Some
Carbidopa anhydrous	Is a	Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	3
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet	Has basis of strength substance (attribute)	True	Carbidopa anhydrous	Inferred relationship	Some	2

This concept is not in any reference sets